Axiom Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.3M Buy
+1,411
New +$1.43M 0.99% 26
2022
Q1
Sell
-1,548
Closed -$428K 129
2021
Q4
$428K Hold
1,548
0.41% 64
2021
Q3
$357K Sell
1,548
-1,090
-41% -$269K 0.36% 67
2021
Q2
$605K Buy
2,638
+76
+3% +$15.3K 0.47% 56
2021
Q1
$479K Buy
2,562
+27
+1% +$5.28K 0.39% 70
2020
Q4
$436 Buy
2,535
+960
+61% +$143K 0.4% 59
2020
Q3
$234K Sell
1,575
-92
-6% -$14.2K 0.26% 95
2020
Q2
$274K Hold
1,667
0.36% 77
2020
Q1
$231K Sell
1,667
-93
-5% -$12.8K 0.41% 72
2019
Q4
$232K Sell
1,760
-9,642
-85% -$1.12M 0.33% 91
2019
Q3
$1.27M Sell
11,402
-30,153
-73% -$3.36M 0.97% 27
2019
Q2
$4.6M Buy
41,555
+262
+0.6% +$30.9K 0.83% 26
2019
Q1
$5.36M Sell
41,293
-884
-2% -$107K 1.02% 20
2018
Q4
$4.88M Buy
+42,177
New +$4.71M 1.03% 20

Other funds holding LLY

Axiom Investment Management's LLY Position: Q1 2026 in Review

Axiom Investment Management opened a new position in Eli Lilly (LLY) in Q1 2026: 1,411 shares worth $1.3M. The stake represents 0.99% of the portfolio and ranks #26 among its holdings. This is a return to the name: Axiom Investment Management previously reported a position in LLY as recently as Q4 2021.

Axiom Investment Management first reported a position in LLY in Q4 2018 and has held it in 14 quarters since. The position peaked at $5.36M in Q1 2019. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Axiom Investment Management held 1,411 shares of Eli Lilly worth $1.3M as of Q1 2026.
  • Eli Lilly was a new Axiom Investment Management position in Q1 2026.
  • Eli Lilly made up 0.99% of Axiom Investment Management's portfolio in Q1 2026, its #26 holding.
  • Axiom Investment Management first reported a position in Eli Lilly in Q4 2018 and has held it in 14 quarters since.
  • Axiom Investment Management's Eli Lilly position peaked at $5.36M in Q1 2019.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Axiom Investment Management's 13F filing for Q1 2026, filed 26 May 2026.